Erratum.

Abstract

ErratumFree Access Erratum This article corrects the following: The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice , Volume 59Issue 1Headache: The Journal of Head and Face Pain pages: 1-18 First Published online: December 10, 2018 First published: 01 April 2019 https://doi.org/10.1111/head.13506AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat American Headache Society, (2019), The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice. Headache: The Journal of Head and Face Pain, 59: 1-18. doi:10.1111/head.13456. Please note that Table 1 of the article The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice1 has been corrected to reflect the fact that episodic migraine is not referenced in the ICHD-3.2 Only Migraine and Chronic Migraine are addressed. A corrected version of Table 1 appears below. Table 1. ICHD-3 Criteria for Migraine and Chronic Migraine1 Migraine At least 5 attacks fulfilling criteria B-D Headache attacks lasting 4-72 hours (when untreated or unsuccessfully treated) Headache has at least 2 of the following 4 characteristics: Unilateral location Pulsating quality Moderate or severe pain intensity Aggravation by or causing avoidance of routine physical activity (eg, walking or climbing stairs) During headache at least 1 of the following: Nausea and/or vomiting Photophobia and phonophobia Not better accounted for by another diagnosis Chronic migraine Migraine-like or tension-type-like headache on ≥15 days/month for >3 months that fulfill criteria B and C Occurring in a patient who has had at least 5 attacks fulfilling criteria B-D for migraine without aura and/or criteria B and C for migraine with aura On ≥8 days/month for >3 months, fulfilling any of the following: Criteria C and D migraine without aura Criteria B and C for migraine with aura Believed by the patient to be migraine at onset and relieved by a triptan or ergot derivative Not better accounted for by another diagnosis ICHD, International Classification of Headache Disorders. Please note the following correction to Table 5. The footnote: †Doctor of medicine (MD), doctor of osteopathy (DO), advanced practice provider (DDS (Doctor of Dental Surgery) or DMD (Doctor of medicine in Dentistry or Doctor of Dental Medicine) has been corrected to read as follows: †Doctor of medicine (MD), doctor of osteopathy (DO), advanced practice provider (NP -nurse practitioner, PA—physician assistant), DDS (Doctor of Dental Surgery) or DMD (Doctor of medicine in Dentistry or Doctor of Dental Medicine) References 1 American Headache Society. The American Headache Society position statement on integrating new migraine treatments into clinical practice. Headache. 2019; 59: 1- 18. 2 Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013; 33: 629- 808. Volume59, Issue4April 2019Pages 650-651 ReferencesRelatedInformation